Peptide profiles.

15-amino acid peptide derived from human gastric juice. Promotes tissue repair, gut healing, and angiogenesis. Among the most-researched repair peptides available.

Synthetic fragment of Thymosin Beta-4. Promotes systemic tissue repair through actin regulation and stem cell activation. Often stacked with BPC-157.

The most selective GH secretagogue available. Stimulates strong growth hormone release with minimal cortisol or prolactin side effects. Considered the gold standard secretagogue.

Naturally occurring copper-binding peptide found in human plasma. Declines significantly with age. Influences over 4,000 genes. Strongest evidence base for topical skin applications.

The most commonly prescribed GH secretagogue combination in US longevity medicine. CJC-1295 provides GHRH stimulation while Ipamorelin provides ghrelin receptor stimulation — two complementary pathways for natural GH optimization.

A proprietary AminoClub peptide blend formulated for skin rejuvenation, cellular repair, and anti-aging. Combines synergistic peptides targeting collagen synthesis, skin barrier function, and cellular regeneration.

A proprietary AminoClub peptide blend formulated for metabolic optimization, body composition, and longevity. Targets the GH axis, metabolic pathways, and cellular health simultaneously.

The most researched tissue repair combination in peptide science. BPC-157 and TB-500 work through complementary mechanisms — local repair signaling and systemic actin regulation — making them the gold standard recovery stack.

The most selective growth hormone secretagogue available. Stimulates strong GH release with minimal cortisol or prolactin side effects. Gold standard for GH axis optimization.

Early GH secretagogue notable for strong appetite stimulation via ghrelin pathway. Studied for cachexia and muscle wasting. Also has gastroprotective properties similar to BPC-157.

Modified IGF-1 with 3x longer half-life. Directly stimulates muscle protein synthesis and satellite cell activation independent of the GH axis. Significant cancer risk concern.

Myostatin inhibitor studied for exceptional muscle growth by blocking the body's natural muscle-growth limiter. Dramatic animal model results. Significant organ growth safety concerns.

Tripeptide fragment of alpha-MSH with potent gut anti-inflammatory effects. One of the few peptides with genuine oral bioavailability making it uniquely valuable for gut-specific research.

Mitochondria-targeted tetrapeptide that protects the inner mitochondrial membrane. Reduces oxidative stress and restores ATP production. In Phase II and III clinical trials for heart failure and Barth syndrome.

A synthetic tripeptide (Ala-Glu-Asp) from the Khavinson family of short peptide bioregulators. Studied in cell culture for cartilage matrix biology and connective tissue gene expression. Evidence is entirely preclinical — cell culture and gene expression studies from a single Russian research group. No human clinical trials exist as of 2026.

A synthetic 11-amino acid peptide derived from erythropoietin (EPO) that selectively activates the Innate Repair Receptor (IRR) without stimulating red blood cell production. Studied for neuropathic pain, small fiber neuropathy, sarcoidosis, and metabolic syndrome. Has completed Phase II human trials. Genuinely interesting evidence profile for a non-hematopoietic EPO derivative.